ORL · 2015 · 51 citations · 16 references
MedicineOncologyPathologyCancer ImmunologyEndocrine OncologyImmunopathologyThyroid CancerThyroid DisordersThyroid EndocrinologyClinicopathological CorrelationFollicular Thyroid Neoplasm PathologyLeukocyte CountsLymphocyte PhenotypingNeutrophil-to-lymphocyte RatioPapillary Thyroid Carcinoma PathologyPlatelet-to-lymphocyte RatioThyroid Cancer Pathology
AIM: The aim of this study is to explore the relationship between the neutrophil-to-lymphocyte ratio (NLR) and clinicopathological features in patients with papillary thyroid carcinoma (PTC). METHODS: We performed an analysis of 843 patients, including 321 patients with PTC, 83 patients with thyroid adenoma and 439 patients with nodular goiter (NG). Thyroglobulin and thyrotropin were measured in each patient. Neutrophils, lymphocytes, and platelets were counted. Statistical analysis was used to correlate the NLR with demographic and histopathologic characteristics of the patients. RESULT: Age correlated with NLR and lymphocyte number in patients with PTC and NG. In patients aged >45 years, those with PTC had a higher NLR and a lower lymphocyte count than those with NG. Patients with PTC aged <45 years had a higher leukocyte count and a lower NLR than those aged ≥45 years. Patients with clinical stage I/II PTC had a lower NLR and a higher lymphocyte count than patients with stage III/IV. CONCLUSIONS: Younger patients with PTC had a higher lymphocyte count but a lower NLR than older patients with PTC. The NLR and lymphocyte counts were associated with the clinical stage. Thus, a higher NLR and a lower lymphocyte count may be prognostic for stratifying patients with thyroidal goiters and are risk factors of PTC for older patients.
16
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
Michael Proctor, Donald C. McMillan, David Morrison et al. · British Journal of Cancer · 2012 · 519 citations · Full text
Medicine, Hematology, Oncology +15